1.The facial nevi associated with hydrocephalus and intracranial anomalous venous return of 3 case reports
Yongjian JIN ; Zengwei FENG ; Jidong SUN ; Qing XIAO ; Guoqiang CHEN ; Huancong ZUO
Chinese Journal of Neurology 2009;42(10):660-663
Objective To study the clinical manifestation of intracranial anomalous venous return associated with the facial nevi and hydrocephalus. Methods Along with reviewing of the literatures, the clinical records of 3 patients suffered from the facial nevi and hydrocephalus were analyzed. Results All of 3 patients also have sinovenous occlusion, which affect cerebral venous return. Conclusions Intracranial anomalous venous return, which is induced by extensive sinovenous occlusion, has been considered to be the main cause of hydrocephalus in the facial nevi. The formation of sinovenous occlusion and anomalous venous return may be due to developmental defect in the embryonic stage.
2.Research progress in low-dose radiotherapy for osteoarthropathy
Yang FENG ; Zengwei HAN ; Yuan YAO ; Dong LI
Chinese Journal of Radiation Oncology 2024;33(3):269-274
Osteoarthropathy is a common chronic disease among middle-aged and elderly populations, characterized by joint pain, limited mobility, and even disability in severe cases. Treatment methods include weight control, functional exercise, local or systemic medication use, and ultimately joint replacement surgery. However, patients often experience ineffective drug treatment or inability to tolerate adverse drug reactions, as well as inability to tolerate joint replacement surgery. Multiple studies have shown that low-dose radiotherapy can alleviate joint pain and limited mobility by regulating multiple stages of the inflammatory process. In addition, the risk of secondary malignant tumors is extremely low, with rare acute and chronic adverse reactions. However, there is still some controversy regarding the optimal segmentation method for radiotherapy in clinical applications, which remains to be elucidated by more prospective studies. Low-dose radiotherapy for osteoarthropathy has been rarely studied in China. This non-invasive, safe, and effective treatment is expected to provide more treatment options for Chinese patients with osteoarthritis.